Ascendis Pharma A/S (ASND) Q1 2026 Earnings

11FebConfirmed
Q4 2024
Q1 2025
Q2 2025
Q1 2026
-1.66
-1.14
-0.62
-0.09

Details

Expected EPS
-0.0944775844
Actual EPS
-0.6459805
Surprise EPS
-0.55
Surprise Percent
+583.74%

Description

Ascendis Pharma A/S (ASND) has reported earnings of -0.6459805 per share for Q1 2026.

0 Comments

Share your thoughts